Recomendaciones para el manejo del riesgo cardiorrenal en el paciente con diabetes mellitus tipo 2
No hay miniatura disponible
Fecha
2020
Autores
Castillo Barriosa, Gilberto Amed
Aroca Martínez, Gustavo
Castillo Barrios, Gilberto Amed
Buelvas Herazo, Jannes
Buitrago S., Andrés F.
Carballo Zárate, Virgil
Cárdenas Castellanos, Juan Mauricio
Gómez López, Efraín Alonso
Fériz Bonelo, Karen
Lopera Vargas, John Mauricio
Título de la revista
ISSN de la revista
Título del volumen
Editor
Sociedad Colombiana de Cardiología & Cirugía Cardiovascular
Resumen
Los pacientes diabéticos tipo 2 tienen mayor riesgo de desarrollar complicaciones
cardiovasculares y renales. La evidencia científica respecto a cómo se debe abordar de manera
integral al paciente diabético para prevenir complicaciones cardiorrenales sigue cambiando con
rapidez. En los estudios de seguridad cardiovascular los nuevos medicamentos antidiabéticos
han demostrado que reducen el desenlace cardiovascular combinado y el deterioro de la función
renal. Otros antidiabéticos reducen también el riesgo de hospitalizaciones por insuficiencia
cardiaca. Este documento plantea la posición de cuatro sociedades científicas a través de sus
expertos delegados, que se encargaron de responder a quince preguntas relacionadas con la
prevención y el tratamiento del riesgo cardiorrenal en los pacientes con diabetes mellitus tipo
2.
Patients with type 2 diabetes mellitus have a higher risk of developing cardiovascular and renal problems. The scientific evidence as regards how this must be approached in the diabetic patient in an integrated manner in order to prevent complications continues changing rapidly. In cardiovascular safety studies, the new anti-diabetic drugs have demonstrated that they reduce the combined cardiovascular outcome and deterioration of kidney function. Other anti-diabetic drugs also the risk of hospital admission due to heart failure. This document sets out the position of four scientific societies through their expert committees, who were also responsible for replying to fifteen
Patients with type 2 diabetes mellitus have a higher risk of developing cardiovascular and renal problems. The scientific evidence as regards how this must be approached in the diabetic patient in an integrated manner in order to prevent complications continues changing rapidly. In cardiovascular safety studies, the new anti-diabetic drugs have demonstrated that they reduce the combined cardiovascular outcome and deterioration of kidney function. Other anti-diabetic drugs also the risk of hospital admission due to heart failure. This document sets out the position of four scientific societies through their expert committees, who were also responsible for replying to fifteen
Descripción
Palabras clave
Diabetes mellitus tipo 2, Complicaciones cardiovasculares, Enfermedad renal diabética, Insuficiencia cardiaca, Riesgo cardiovascular, Type 2 diabetes mellitus, Cardiovascular complications, Diabetic kidney disease, Heart failure, Cardiovascular risk
